Cargando...
Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials
This study evaluates the inclusion of studies identified by the FDA as having falsified data in the results of meta-analyses.
Gardado en:
| Publicado en: | JAMA Intern Med |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Medical Association
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6450302/ https://ncbi.nlm.nih.gov/pubmed/30830216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.7661 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|